We are live on ! Find out more
KIN

Kindred Biosciences
KIN

Delisted

KIN was delisted on the 27th of August, 2021.

50 hedge funds and large institutions have $38.9M invested in Kindred Biosciences in 2015 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 22 increasing their positions, 3 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

633% more repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 3

50% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 10

11% more funds holding

Funds holding: 45 → 50 (+5)

3.45% less ownership

Funds ownership: 61.06% → 57.61% (-3.5%)

26% less capital inflows, than outflows

Capital inflows: $15.4M | Capital outflows: $20.7M

Holders
50
Holders Change
+5
Holders Change %
+11.11%
% of All Funds
1.31%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
15
Increased
22
Reduced
3
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

KIN Hedge Fund Activity: Q4 2015 in Review

50 of the 3,824 institutional investors tracked by Wall St. Rank reported a position in Kindred Biosciences (KIN) for Q4 2015, worth a combined $38.9M — down 38% from $62.9M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new KIN positions and 10 closed out — a net gain of 5 holders — while 22 added to existing stakes and 3 trimmed.

The largest buyer was Park West Asset Management, adding an estimated $6.78M. The largest seller was Jennison Associates, exiting entirely with an estimated $11.3M sold.

  • 50 institutional investors held Kindred Biosciences (KIN) as of Q4 2015, up from 45 in Q3 2015.
  • Funds reported $38.9M of Kindred Biosciences stock for Q4 2015, down 38% quarter-over-quarter.
  • 15 funds opened new Kindred Biosciences positions in Q4 2015 and 10 closed out, a net change of +5 holders.
  • The largest Kindred Biosciences buyer in Q4 2015 was Park West Asset Management, an estimated $6.78M added.
  • The largest Kindred Biosciences seller in Q4 2015 was Jennison Associates, an estimated $11.3M sold.

Based on aggregated 13F filings for Q4 2015.